MENU

Future Research Leaders: Dr Eliana Marino talks to JDRF
Published on July 14, 2017

Dr Eliana Marino is one of our first seven participants in the pilot year of the JDRF/Macquarie Group Foundation Future Research Leaders Program (FRLP). Hailing from Venezuela, the bubbly Dr Marino speaks with exuberance and energy. She sees beyond what’s happening on the laboratory benchtop, to how the type 1 diabetes community will benefit as […]

Share

At the world’s largest diabetes research conference, held last month, JDRF-funded researchers highlighted exciting breakthroughs and vital work that is paving the way to new type 1 diabetes therapies. More than 18,000 physicians, researchers, health care professionals and patient advocates attended the event, which highlights the latest findings in all major areas of the diabetes research […]

Share

An American research team, partly funded by JDRF, have developed a hydrogel material that increased islet survival and function after transplantation in mice. The research, published in Science Advances, used a degradable hydrogel material combined with a protein called vascular endothelial growth factor (VEGF), to stimulate the growth of blood vessels into transplanted cells.

Share

 Two promising research projects have been targeted to receive contract seed funding grants, and will benefit from $350k in funding from the Type 1 Diabetes Clinical Research Network (T1DCRN), itself an innovative clinical research program led by JDRF Australia and funded by a Special Research Initiative through the Australian Research Council (ARC). These two projects […]

Share

A new technique that uses modified insulin and red blood cells to create a glucose-responsive insulin (GRI) delivery system has been developed by researchers from North Carolina State University and the University of North Carolina in the USA. The new technique effectively reduced blood sugar levels for more than 48 hours in mice that had type 1 diabetes. […]

Share

About one third of individuals with type 1 diabetes will develop kidney complications during their lifetime. Current treatment options for diabetic kidney disease can slow but not stop its progression, highlighting an urgent need for new approaches. Scientists at Boston’s Joslin Diabetes Center have revealed an unexpected route to slow the progression of diabetic kidney […]

Share
Six things to know about clinical trials
Published on May 19, 2017

This year, 20 May 2017 is International Clinical Trials Day, which aims to help raise awareness of the important role clinical trials play in public health and medical progress. Despite how critical these trials are to finding therapies to cure, prevent and treat type 1 diabetes (T1D), many people have questions about how clinical trials […]

Share
Lachie is not too busy
Published on May 4, 2017

Sixteen year old Lachlan has such a busy life that if we listed all his hobbies and interests here, we’d have no room for anything else. Alongside debating, art and technology, he’s an accomplished sportsman on field and in pool. He also does a little kite-surfing in his spare time. There’s one other interest that […]

Share
Securing the talented future of type 1 diabetes research
Published on April 27, 2017

JDRF is excited to announce that the JDRF/Macquarie Group Foundation Future Research Leaders Program (FRLP) pilot launched this month. Seven of the best and brightest rising stars of type 1 diabetes research, specialising in areas including glucose control, complications, immunology and beta cell biology are the first group to go through the program in its […]

Share
Stressed-out beta cells masters of own demise?
Published on March 30, 2017

The prevailing belief on how type 1 diabetes (T1D) develops is that the immune system mistakenly identifies insulin-producing beta cells as foreign, leading to their destruction. A new study published in Nature Medicine has found beta cells themselves may be causing the destructive immune response that leads to T1D. This is a relatively new concept […]

Share